Loading...
OTCMIMEXF
Market cap113kUSD
Dec 23, Last price  
0.00USD
1Q
-99.99%
Jan 2017
-100.00%
Name

Imagin Medical Inc

Chart & Performance

D1W1MN
OTCM:IMEXF chart
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
1,883646000000000000000000
Net income
-3m
L-78.22%
-521,059-134,233-1,355,562-1,348,996-2,157,548-8,052,251-5,614,237-64,292-1,739,181-1,892,940-493,373-2,014,360-402,757-2,259,571-1,542,102-7,958,086-4,464,541-4,384,766-11,480,341-2,500,041
CFO
-3m
L-35.83%
-80,877-199,279-299,291-778,811-1,323,383-174,012-507,236-472,891-525,086-364,381-403,860-456,384-256,423-1,404,217-664,319-4,629,592-4,037,376-4,111,989-4,094,026-2,627,210

Profile

Imagin Medical Inc. operates as a surgical imaging company focusing on bladder cancer. The company is developing the i/Blue Imaging System to meet the BLC needs of urologists. Imagin Medical Inc. was founded in 1986 and is headquartered in Vancouver, Canada.
URL
https://imaginmedical.com/
IPO date
Apr 30, 1987
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2022‑092021‑092020‑092019‑092018‑092017‑092016‑092015‑09
Income
Revenues
Cost of revenue
3,502
Unusual Expense (Income)
NOPBT
(3,502)
NOPBT Margin
Operating Taxes
8
Tax Rate
NOPAT
(3,510)
Net income
(2,500)
-78.22%
Dividends
Dividend yield
Proceeds from repurchase of equity
14
BB yield
-0.47%
Debt
Debt current
13,456
Long-term debt
Deferred revenue
Other long-term liabilities
14,181
Net debt
13,415
Cash flow
Cash from operating activities
(2,627)
CAPEX
(781)
Cash from investing activities
(781)
Cash from financing activities
3,183
FCF
(2,465)
Balance
Cash
40
Long term investments
Excess cash
40
Stockholders' equity
(16,476)
Invested Capital
16,597
ROIC
ROCE
EV
Common stock shares outstanding
9,998
Price
0.29
-38.95%
Market cap
2,900
-32.55%
EV
16,315
EBITDA
(3,455)
EV/EBITDA
Interest
8
Interest/NOPBT